Totality of Evidence Supporting the Use of ABP 980, a Trastuzumab Biosimilar: Practical Considerations
Version 6 2021-01-29, 08:49
Version 5 2021-01-14, 11:41
Version 4 2021-01-14, 11:14
Version 3 2021-01-11, 16:51
Version 2 2020-12-24, 09:24
Version 1 2020-12-17, 17:41
media
posted on 2021-01-29, 08:49 authored by Hans-Christian Kolberg, Georgia Savva Demetriou, Vladimir Hanes<p><strong>Article full
text</strong></p>
<p><br>
The above summary slide and videos represent the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.<b> </b></p>
History
Related Materials
- 1.
- 2.
